Genetic testing company 23andMe had 15 million consumers who turned to them to learn more about their ancestry and understand their disposition to diseases.

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and ...

Welcome back to Week in Review! Tons of news from this week for you, including a hacking group that's linked to the Spanish ...

This time at I/O, Google appeared to get the upper hand, vibe-wise, with a flurry of new models and features, a vision of a ...

Jeremiah Fowler describes the dataset as 'one of the most dangerous discoveries I have found in a very long time.' He shares ...

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on the recent downgrade of US credit. In a surprising development that led markets to end flat during ...

PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data ...

A 23AndMe spokesperson told Bloomberg that the website delays were due to heavy site traffic. This comes in the wake of the company's weekend bankruptcy filing. In other news: McCormick begins ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

Before, we told you to delete your data because 23andMe was about to be sold. Now, a buyer has been announced, and they’re ...

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

Regeneron is set to acquire 23andMe’s consumer genetics and research assets for $256 million. Here’s what the deal means for ...